Purdue's offer adds to its efforts to refashion the company as an advocate for fighting the addiction crisis while fighting back court cases. (Photo: Shutterstock)
The company that created OxyContin is offering free doses of an opioid-abuse treatment as part of its offer to resolve more than 1,000 lawsuits accusing the drugmaker of helping fuel the opioid crisis, according to people familiar with the negotiations.
Purdue Pharma has repeatedly said it will give away doses of a new version of buprenorphine — which helps wean people addicted to opioids off the drugs — as part of any settlement, according to four people familiar with the talks sponsored by state attorneys general and a federal judge. They asked not to be cited by name as the negotiations are confidential.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
